spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Influenza Vaccine 

 HSMN NewsFeed - 15 Feb 2023
Codagenix Announces Close of $25 million Extension of Series B
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Oct 2021
Novavax Announces Leadership Appointment and Updates
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2020
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 18 Nov 2019
Enrollment and Randomization of 12,463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine trial
Biopharmaceuticals
 HSMN NewsFeed - 11 Oct 2019
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2018
BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jun 2018
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2018
GSK receives FDA approval for expanded indication for FLUARIX(R) QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Dec 2017
BiondVax Plans Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines Agency (EMA)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Feb 2017
Glide Technologies Announces Successful £3.2 Million ($4.0 Million) Fundraising
Devices Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 2 Jan 2017
BiondVax Receives $US 2.8 Million Investment From Angels High Tech Investments Ltd.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Nov 2016
GSK Receives FDA Approval for Expanded Indication for Flulaval(R) Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Apr 2016
Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2016
Tokai Strengthens Development Team Through the Addition of Kelly Lindert, M.D., as Executive Vice President and Head of Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Dec 2014
Sanofi Pasteur Announces FDA Approval of Fluzone(R) Intradermal Quadrivalent (Influenza Vaccine) for Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Aug 2014
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 30 Jul 2014
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Jul 2014
Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer
Biopharmaceuticals Diagnostics Oncology Licensing
 HSMN NewsFeed - 3 Mar 2014
PaxVax Announces New Commercial Senior Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2014
Osiris Therapeutics Promotes Frank Czworka to Vice President and General Manager of Wound Care
Devices Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 27 Jan 2014
Synthetic Biologics Strengthens Clinical & Regulatory Team to Support Expanding Pipeline of Infectious Disease Programs
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 6 Jan 2014
Microbix Sues Novartis for Infringement of its VIRUSMAX(R) Patent
Biopharmaceuticals Litigation
 HSMN NewsFeed - 4 Dec 2013
PaxVax Secures $22 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Aug 2013
Additional GlaxoSmithKline quadrivalent intramuscular influenza vaccine approved by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jan 2013
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 4 Sep 2012
Two New Executives Join VaxInnate Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2012
PaxVax Expands Executive Management Team
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 12 Sep 2011
Immunovaccine Announces Appointment of John Trizzino as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Oct 2010
Synthetic Genomics Inc. and J. Craig Venter Institute Form New Company, Synthetic Genomics Vaccines Inc. (SGVI), to Develop Next Generation Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2010
Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2010
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jan 2010
Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2009
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Sep 2009
Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA(R), Seasonal Influenza Vaccine from CSL Biotherapies
Biopharmaceuticals Distribution
 HSMN NewsFeed - 28 Sep 2009
CSL Biotherapies Reaches Agreement with Merck & Co. on Rights to Market and Distribute Afluria(R) in the U.S.
Biopharmaceuticals Distribution
 HSMN NewsFeed - 28 Sep 2009
Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2009
Abbott to Acquire Solvay Pharmaceuticals Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jul 2009
Ted Karkus Named CEO of The Quigley Corporation; Robert V. Cuddihy, Jr. Named Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2009
Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
Biopharmaceuticals
 HSMN NewsFeed - 8 Jul 2009
NanoBio Announces Closing of $22 Million Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Feb 2009
NanoBio Corporation Raises $12 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Feb 2009
Genocea Biosciences Names Jane Halpern Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2009
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Sep 2008
Greg MacMichael, Ph.D., Joins Cook Pharmica as Vice President of Development, CSO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2008
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 7 Jul 2008
Inovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Jun 2008
Immune Design Announces $18 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2008
CytoDyn Appoints Dr. Nader Z. Pourhassan Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Mar 2008
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2008
FDA Approves LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Feb 2008
Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S. Food and Drug Administration for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 30 Jan 2008
Solvay Pharmaceuticals, Inc. Announces Retirement of CEO Laurence Downey and Appointment of Stephen Hill as New President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2007
Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Sep 2007
CSL Biotherapies announces FDA marketing approval of Afluria(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Sep 2007
MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Sep 2007
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2007
Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2007
Vical Names Andrew de Guttadauro Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2007
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Aug 2007
Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc. Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jul 2007
Quidel Corporation Announces Exclusive Licenses to Molecular Antiviral Resistance and Detection Technology for Influenza
Diagnostics Licensing
 HSMN NewsFeed - 10 Jul 2007
ViroPharma Announces Key Additions to European Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2007
Novavax Licenses Wyeth's Virus-Like Particle Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Jul 2007
Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jun 2007
GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2007
Akorn Inc. Names Douglas R. Pinnell As Vice President, Vaccine Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2007
FDA Advisory Committee Recommends Expanded Use of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Apr 2007
FDA Licenses First U.S. Vaccine for Humans Against Avian Influenza
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Mar 2007
David Taylor, MD, Joins VaxInnate as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2007
Roche Files Supplemental New Drug Application with U.S. Food & Drug Administration for Tamiflu(R) 30 mg and 45 mg Capsules
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2007
AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
Biopharmaceuticals
 HSMN NewsFeed - 17 Jan 2007
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
FDA Approves MedImmune's Refrigerated Formulation of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Dec 2006
Sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2006
Phase 2 and 3 Clinical Data for Bifeprunox in Patients With Schizophrenia Showed Improvement of Symptoms and Maintenance of Stability With Fewer Metabolic Side Effects Versus Placebo
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2006
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Shows Statistically Significant Results in Phase 3 Trial
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2006
DelSite Presents Influenza Nasal Powder Vaccine Data
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Oct 2006
Pfizer Expands Commitment to Fight Infectious Diseases With Agreement to Acquire Vaccine Company PowderMed Ltd
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Oct 2006
NEW ENGLAND JOURNAL OF MEDICINE Reports Positive Results From Dynavax' Ragweed Allergy Therapy Trial
Biopharmaceuticals
 HSMN NewsFeed - 2 Oct 2006
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Oct 2006
Novavax Names Dr. Penny Heaton Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2006
Unimed Pharmaceuticals, Inc. Settles AndroGel(R) Litigation with Watson Pharmaceuticals, Inc. and Paddock Laboratories/Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 6 Sep 2006
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Jul 2006
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2006
MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jul 2006
Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to CREON(R) MINIMICROSPHERES(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 May 2006
SciClone Reports Final Results From Second ZADAXIN U.S. Phase 3 Hepatitis C Trial
Biopharmaceuticals
 HSMN NewsFeed - 11 May 2006
Novavax Strengthens Vaccine Development Team with Two New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2006
Norwood Abbey Highlights Needle-Free Drug Delivery System and Commercial Strategic Update
Devices Drug Delivery Licensing
 HSMN NewsFeed - 4 May 2006
Novartis Awarded Up to USD220 Million by U.S. Department of Health and Human Services for Development of Cell Culture-Derived Influenza Vaccine
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 53

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 53 additional stories matching:
Influenza Vaccine
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.